Diphtheria, tetanus, pertussis, polio, hepatitis b, Haemophilus influenzae type b vaccine
Infanrix-hexa
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/HML/archive/2026/2026-10-01/HML_2026-10-01.xml; October 2026; published 2026-10-01; acquired 2026-10-13T22:49:54.923639+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.
Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substances
- Diphtheria, tetanus, pertussis, polio, hepatitis b, Haemophilus influenzae type b vaccine
- Dosage form
- Inj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe
- Register
- New Zealand (PHARMAC)